Phase 1 Study of C.001 in Retinal Degeneration
Abroad (travel likely)RecruitingPHASE1
Conditions
Geographic Atrophy · Stargardt Disease · RPE-mediated Maculopathy · Age Related Macular Degeneration
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Clinical Trial Site 1, Beverly Hills, California, United States
Contact: Study coordinator (Clinical Trial Administer) · regulatory@celliotherapeutics.com · regulatory@celliotherapeutics.